{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:43:48Z","timestamp":1794408228842,"version":"4.9.0"},"reference-count":307,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010382","name":"European Society of Endocrinology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010382","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In the present European Society of Endocrinology (ESE) clinical guideline, we present recommendations for the diagnosis, management, and monitoring of chronic hypoparathyroidism (HypoPT) in adults. Management of HypoPT has changed since the first ESE clinical guideline was published in 2015, as has the knowledge on patient burden of the disease, and the understanding of associated morbidities. In line with the ESE policy, the 2015 guidelines were updated based on up-to-date scientific evidence.<\/jats:p>\n                  <jats:p>As HypoPT is an orphan disease, strong evidence for most outcomes is scarce and recommendations were based on careful synthesis of the literature and expert opinion. Postsurgical HypoPT should be defined as persisting more than 12 months following surgery; recovery could be expected even thereafter (clinical question I [Q I]). For Q II (optimal treatment of chronic HypoPT), relevant data regarding conventional treatment are lacking for clinically relevant endpoints and long-term effects. PTH replacement therapy reduces the pill burden of conventional therapy, improves various biochemical parameters, and potentially improves QoL. We cannot recommend a substantial role for parathyroid allotransplantation in the treatment of chronic HypoPT (Q III).<\/jats:p>\n                  <jats:p>In conclusion, we present recommendations for the diagnosis, management, and monitoring of chronic HypoPT in adults, to give health care providers practical clinical guidance on the management of this condition. The guideline can serve as a source for preparation of educational materials to empower patients and clinicians.<\/jats:p>","DOI":"10.1093\/ejendo\/lvaf222","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:55:07Z","timestamp":1762865707000},"page":"G83-G112","source":"Crossref","is-referenced-by-count":47,"title":["Revised European Society of Endocrinology Clinical Practice Guideline: Treatment of Chronic Hypoparathyroidism in Adults"],"prefix":"10.1093","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0654-4610","authenticated-orcid":false,"given":"Jens","family":"Bollerslev","sequence":"first","affiliation":[{"name":"Faculty of Medicine, University of Oslo , 0372 Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ottilia","family":"Buch","sequence":"additional","affiliation":[{"name":"Endocrinology Centre, York and Scarborough Teaching Hospitals NHSFT , YO31 8HE York ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds Miguel","family":"Cardoso","sequence":"additional","affiliation":[{"name":"Local Health Unity of Coimbra, and Institute for Research and Innovation in Health of the University of Porto , 4099-002 Porto ,","place":["Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Gittoes","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology, Diabetes and Metabolism, University of Birmingham & Queen Elizabeth Hospital , Birmingham B15 2GW ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Houillier","sequence":"additional","affiliation":[{"name":"Service de Physiologie, H\u00f4pital Europ\u00e9en Georges-Pompidou, Assistance Publique - H\u00f4pitaux de Paris , 75015 Paris ,","place":["France"]},{"name":"Centre de R\u00e9f\u00e9rence des Maladies Rares du Calcium et du Phosphate , Endo-ERN, 75015 Paris ,","place":["France"]},{"name":"Centre de Recherche des Cordeliers, INSERM, Sorbonne Universit\u00e9, Universit\u00e9 Paris Cit\u00e9 , 75006 Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2617-5429","authenticated-orcid":false,"given":"Leonie","family":"van Hulsteijn","sequence":"additional","affiliation":[{"name":"European Society of Endocrinology , Bristol BS32 4QW ,","place":["UK"]},{"name":"Department of Clinical Epidemiology, Leiden University Medical Center , 2333 ZA Leiden ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6660-6748","authenticated-orcid":false,"given":"Ozer","family":"Makay","sequence":"additional","affiliation":[{"name":"\u00d6zel Sa\u011fl\u0131k Hospital, Centre for Endocrine Surgery , 35000 Izmir ,","place":["T\u00fcrkiye"]},{"name":"Aristotle University, School of Medicine , Thessaloniki 54124 ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Marcocci","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Pisa , 56126 Pisa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Carl","family":"Pallais","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women\u2019s Hospital and Harvard Medical School , Boston, MA, 02115 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7959-1311","authenticated-orcid":false,"given":"Stefan","family":"Pilz","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz , 8010 Graz ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Rejnmark","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Aarhus University Hospital , 8200 Aarhus ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Yavropoulou","sequence":"additional","affiliation":[{"name":"First Department of Propaedeutic and Internal Medicine, National and Kapodistrian University of Athens, LAIKO General Hospital of Athens, Centre of Excellence for Rare Endocrine Diseases (CERED) , Athens 115 27 ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1333-7580","authenticated-orcid":false,"given":"Olaf M","family":"Dekkers","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology, Leiden University Medical Center , 2333 ZA Leiden ,","place":["The Netherlands"]},{"name":"Department of Endocrinology and Metabolism, Leiden University Medical Center , 2333 ZA Leiden ,","place":["The Netherlands"]},{"name":"Department of Clinical Epidemiology, Aarhus University , 8200 Aarhus ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"issue":"5","key":"2026032704271243600_lvaf222-B1","first-page":"4101","article-title":"Scientific Opinion on Dietary Reference Values for calcium","volume":"13","author":"EFSA Panel on Dietetic Products, N. and Allergies","year":"2015","journal-title":"EFSA Journal"},{"issue":"6","key":"2026032704271243600_lvaf222-B2","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1210\/jc.2015-3909","article-title":"Presentation of Hypoparathyroidism: Etiologies and Clinical Features","volume":"101","author":"Shoback","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026032704271243600_lvaf222-B3","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-15-0628","article-title":"European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyroidism in adults","volume":"173","author":"Bollerslev","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"2026032704271243600_lvaf222-B4","doi-asserted-by":"crossref","DOI":"10.1530\/EJE-19-0316","article-title":"MANAGEMENT OF ENDOCRINE DISEASE: Unmet therapeutic, educational and scientific needs in parathyroid disorders","author":"Bollerslev","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2026032704271243600_lvaf222-B5","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1210\/jc.2015-3907","article-title":"Management of Hypoparathyroidism: Summary Statement and Guidelines","volume":"101","author":"Brandi","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2026032704271243600_lvaf222-B6","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1210\/jc.2016-1477","article-title":"Epidemiology and Health-Related Quality of Life in Hypoparathyroidism in Norway","volume":"101","author":"Astor","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026032704271243600_lvaf222-B7","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.ecl.2018.07.004","article-title":"Epidemiology and Complications of Hypoparathyroidism","volume":"47","author":"Clarke","year":"2018","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"11","key":"2026032704271243600_lvaf222-B8","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1002\/jbmr.1979","article-title":"Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study","volume":"28","author":"Underbjerg","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2026032704271243600_lvaf222-B9","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.chembiol.2013.12.016","article-title":"Vitamin D metabolism, mechanism of action, and clinical applications","volume":"21","author":"Bikle","year":"2014","journal-title":"Chem Biol"},{"issue":"9","key":"2026032704271243600_lvaf222-B10","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/jbmr.2501","article-title":"The Epidemiology of Nonsurgical Hypoparathyroidism in Denmark: A Nationwide Case Finding Study","volume":"30","author":"Underbjerg","year":"2015","journal-title":"J Bone Miner Res"},{"issue":"12","key":"2026032704271243600_lvaf222-B11","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1002\/jbmr.2004","article-title":"Prevalence and incidence of hypoparathyroidism in the United States using a large claims database","volume":"28","author":"Powers","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"9","key":"2026032704271243600_lvaf222-B12","doi-asserted-by":"crossref","first-page":"ziae100","DOI":"10.1093\/jbmrpl\/ziae100","article-title":"Prevalence and characteristics of postoperative and nonoperative chronic hypoparathyroidism in Japan: a nationwide retrospective analysis","volume":"8","author":"Hasegawa","year":"2024","journal-title":"JBMR Plus"},{"issue":"12","key":"2026032704271243600_lvaf222-B13","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1002\/jbmr.4667","article-title":"Hypoparathyroidism: Genetics and Diagnosis","volume":"37","author":"Mannstadt","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2026032704271243600_lvaf222-B14","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00198-024-07352-6","article-title":"Hypoparathyroidism: Similarities and differences between Western and Eastern countries","volume":"36","author":"Yang","year":"2025","journal-title":"Osteoporos Int"},{"issue":"6","key":"2026032704271243600_lvaf222-B15","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1530\/EJE-13-0528","article-title":"Addison's disease: a survey on 633 patients in Padova","volume":"169","author":"Betterle","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"2026032704271243600_lvaf222-B16","article-title":"Lessons from prospective longitudinal follow-up of a French APECED cohort","author":"Humbert","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026032704271243600_lvaf222-B17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1530\/EJE-21-0730","article-title":"Spectrum of germline AIRE mutations causing APS-1 and familial hypoparathyroidism","volume":"187","author":"Cranston","year":"2022","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"2026032704271243600_lvaf222-B18","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1210\/jc.2016-1821","article-title":"A Longitudinal Follow-up of Autoimmune Polyendocrine Syndrome Type 1","volume":"101","author":"Bruserud","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2026032704271243600_lvaf222-B19","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa0706487","article-title":"Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen","volume":"358","author":"Alimohammadi","year":"2008","journal-title":"N Engl J Med"},{"issue":"4-5","key":"2026032704271243600_lvaf222-B20","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.autrev.2014.01.044","article-title":"Diagnosis and classification of autoimmune parathyroid disease","volume":"13","author":"Betterle","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"6","key":"2026032704271243600_lvaf222-B21","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-243299","article-title":"Late diagnosis of chronic hypocalcemia due to autoimmune hypoparathyroidism","volume":"14","author":"Teisseyre","year":"2021","journal-title":"BMJ Case Rep"},{"issue":"2","key":"2026032704271243600_lvaf222-B22","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1530\/EJE-10-1206","article-title":"Hypoparathyroidism and autoimmunity in the 22q11.2 deletion syndrome","volume":"165","author":"Lima","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2026032704271243600_lvaf222-B23","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1080\/17446651.2023.2256841","article-title":"Endocrine immune-related adverse effects of immune-checkpoint inhibitors","volume":"18","author":"Trevisani","year":"2023","journal-title":"Expert Rev Endocrinol Metab"},{"issue":"5","key":"2026032704271243600_lvaf222-B24","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa092","article-title":"Activating Antibodies to The Calcium-sensing Receptor in Immunotherapy-induced Hypoparathyroidism","volume":"105","author":"Lupi","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2026032704271243600_lvaf222-B25","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1002\/jbmr.483","article-title":"Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research","volume":"26","author":"Bilezikian","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2026032704271243600_lvaf222-B26","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/ohn.594","article-title":"Management of Postthyroidectomy Hypoparathyroidism and Its Effect on Hypocalcemia-Related Complications: A Meta-Analysis","volume":"170","author":"van Dijk","year":"2024","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"1","key":"2026032704271243600_lvaf222-B27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12020-021-02663-8","article-title":"What are the real rates of temporary hypoparathyroidism following thyroidectomy? It is a matter of definition: a systematic review","volume":"73","author":"Koimtzis","year":"2021","journal-title":"Endocrine"},{"issue":"3","key":"2026032704271243600_lvaf222-B28","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10030543","article-title":"Etiology and Diagnosis of Permanent Hypoparathyroidism after Total Thyroidectomy","volume":"10","author":"Sitges-Serra","year":"2021","journal-title":"J Clin Med"},{"issue":"4","key":"2026032704271243600_lvaf222-B29","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/bjs.9384","article-title":"Systematic review and meta-analysis of predictors of post-thyroidectomy hypocalcaemia","volume":"101","author":"Edafe","year":"2014","journal-title":"Br J Surg"},{"issue":"4","key":"2026032704271243600_lvaf222-B30","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/bjs.9676","article-title":"Importance of in situ preservation of parathyroid glands during total thyroidectomy","volume":"102","author":"Lorente-Poch","year":"2015","journal-title":"Br J Surg"},{"issue":"8","key":"2026032704271243600_lvaf222-B31","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1097\/JS9.0000000000001475","article-title":"Risk factors of transient and permanent hypoparathyroidism after thyroidectomy: a systematic review and meta-analysis","volume":"110","author":"Ning","year":"2024","journal-title":"Int J Surg"},{"issue":"4","key":"2026032704271243600_lvaf222-B32","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.amjsurg.2020.02.036","article-title":"Post-thyroidectomy emergency room visits and readmissions: Assessment from the Collaborative Endocrine Surgery Quality Improvement Program (CESQIP)","volume":"220","author":"Taye","year":"2020","journal-title":"Am J Surg"},{"issue":"4","key":"2026032704271243600_lvaf222-B33","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1210\/clinem\/dgab039","article-title":"Preoperative Vitamin D Deficiency is a Risk Factor for Postthyroidectomy Hypoparathyroidism: A Systematic Review and Meta-Analysis of Observational Studies","volume":"106","author":"Vaitsi","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2026032704271243600_lvaf222-B34","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.bjoms.2023.10.001","article-title":"Incidence of post-surgical hypoparathyroidism (POSH) after total thyroidectomy","volume":"61","author":"Roberts","year":"2023","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"1","key":"2026032704271243600_lvaf222-B35","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1530\/EJE-17-0589","article-title":"Time to parathyroid function recovery in patients with protracted hypoparathyroidism after total thyroidectomy","volume":"178","author":"Villarroya-Marquina","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2026032704271243600_lvaf222-B36","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.amjoto.2018.08.005","article-title":"Prediction of permanent hypoparathyroidism by parathyroid hormone and serum calcium 24\u202fh after thyroidectomy","volume":"39","author":"Wang","year":"2018","journal-title":"Am J Otolaryngol"},{"key":"2026032704271243600_lvaf222-B37","doi-asserted-by":"crossref","first-page":"942488","DOI":"10.3389\/fonc.2022.942488","article-title":"Clinical application of parathyroid autotransplantation in endoscopic radical resection of thyroid carcinoma","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Oncol"},{"issue":"4","key":"2026032704271243600_lvaf222-B38","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S2213-8587(22)00035-3","article-title":"The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020","volume":"10","author":"Pizzato","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"2026032704271243600_lvaf222-B39","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S2213-8587(24)00223-7","article-title":"Evolving epidemiological patterns of thyroid cancer and estimates of overdiagnosis in 2013-17 in 63 countries worldwide: a population-based study","volume":"12","author":"Li","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"2026032704271243600_lvaf222-B40","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1111\/ans.17117","article-title":"Methods of identification of parathyroid glands in thyroid surgery: A literature review","volume":"91","author":"Tjahjono","year":"2021","journal-title":"ANZ J Surg"},{"issue":"3","key":"2026032704271243600_lvaf222-B41","doi-asserted-by":"crossref","DOI":"10.1093\/bjs\/znae307","article-title":"Parathyroid vascular anatomy using intraoperative mapping angiography: the PARATLAS study","volume":"112","author":"Benmiloud","year":"2025","journal-title":"Br J Surg"},{"issue":"6","key":"2026032704271243600_lvaf222-B42","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1097\/JS9.0000000000001247","article-title":"The impact of using near-infrared autofluorescence on parathyroid gland parameters and clinical outcomes during total thyroidectomy: a meta-analytic study of randomized controlled trials","volume":"110","author":"Safia","year":"2024","journal-title":"Int J Surg"},{"key":"2026032704271243600_lvaf222-B43","doi-asserted-by":"crossref","DOI":"10.1210\/js.2019-MON-521","article-title":"Impact of Chronic Hypoparathyroidism on Health-Related Quality of Life: Findings from a 13-Country Patient Survey","author":"Siggelkow","year":"2019","journal-title":"Journal of the Endocrine Society"},{"issue":"11","key":"2026032704271243600_lvaf222-B44","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1002\/jbmr.2273","article-title":"Postsurgical hypoparathyroidism\u2013risk of fractures, psychiatric diseases, cancer, cataract, and infections","volume":"29","author":"Underbjerg","year":"2014","journal-title":"J Bone Miner Res"},{"issue":"7","key":"2026032704271243600_lvaf222-B45","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/jbmr\/zjae063","article-title":"Hypoparathyroidism: changes in brain structure, cognitive impairment, and reduced quality of life","volume":"39","author":"Sikjaer","year":"2024","journal-title":"J Bone Miner Res"},{"issue":"10","key":"2026032704271243600_lvaf222-B46","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1002\/jbmr.470","article-title":"The effect of adding PTH(1-84) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study","volume":"26","author":"Sikjaer","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2026032704271243600_lvaf222-B47","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/cen.13593","article-title":"Health-related quality of life in patients with nonsurgical hypoparathyroidism and pseudohypoparathyroidism","volume":"88","author":"Underbjerg","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2026032704271243600_lvaf222-B48","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/jbmr.3368","article-title":"Long-Term Complications in Patients With Hypoparathyroidism Evaluated by Biochemical Findings: A Case-Control Study","volume":"33","author":"Underbjerg","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2026032704271243600_lvaf222-B49","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/cen.14470","article-title":"Determinants of hypercalciuria and renal calcifications in chronic hypoparathyroidism: A cross-sectional study","volume":"95","author":"Ridder","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"2026032704271243600_lvaf222-B50","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1002\/jbmr.4673","article-title":"Complications, Symptoms, Presurgical Predictors in Patients With Chronic Hypoparathyroidism: A Systematic Review","volume":"37","author":"Yao","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2026032704271243600_lvaf222-B51","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/cen.13895","article-title":"Increased mortality and morbidity in patients with chronic hypoparathyroidism: A population-based study","volume":"90","author":"Vadiveloo","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2026032704271243600_lvaf222-B52","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.ecl.2018.07.009","article-title":"Hypoparathyroidism and the Kidney","volume":"47","author":"Peacock","year":"2018","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"3","key":"2026032704271243600_lvaf222-B53","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.surg.2024.05.005","article-title":"Long-term kidney outcomes in patients with permanent hypoparathyroidism after total thyroidectomy for benign disease: A population-based study","volume":"176","author":"Luk","year":"2024","journal-title":"Surgery"},{"issue":"10","key":"2026032704271243600_lvaf222-B54","doi-asserted-by":"crossref","first-page":"e4098","DOI":"10.1210\/clinem\/dgac456","article-title":"Kidney Complications and Hospitalization in Patients With Chronic Hypoparathyroidism: A Cohort Study in Sweden","volume":"107","author":"Swartling","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026032704271243600_lvaf222-B55","doi-asserted-by":"crossref","first-page":"R37","DOI":"10.1530\/EJE-18-0541","article-title":"MANAGEMENT OF ENDOCRINE DISEASE: Hypoparathyroidism in pregnancy: review and evidence-based recommendations for management","volume":"180","author":"Khan","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2026032704271243600_lvaf222-B56","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1152\/physrev.00027.2015","article-title":"Maternal Mineral and Bone Metabolism During Pregnancy, Lactation, and Post-Weaning Recovery","volume":"96","author":"Kovacs","year":"2016","journal-title":"Physiol Rev"},{"issue":"2","key":"2026032704271243600_lvaf222-B57","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1530\/EJE-21-1044","article-title":"European Expert Consensus on Practical Management of Specific Aspects of Parathyroid Disorders in Adults and in Pregnancy: Recommendations of the ESE Educational Program of Parathyroid Disorders","volume":"186","author":"Bollerslev","year":"2022","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"2026032704271243600_lvaf222-B58","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1210\/clinem\/dgab503","article-title":"Women With Chronic Hypoparathyroidism Have Low Risk of Adverse Pregnancy Outcomes","volume":"106","author":"Bjornsdottir","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026032704271243600_lvaf222-B59","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1530\/eje.0.1390284","article-title":"Management of hypoparathyroidism during pregnancy\u2013report of twelve cases","volume":"139","author":"Callies","year":"1998","journal-title":"Eur J Endocrinol"},{"key":"2026032704271243600_lvaf222-B60","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/IJNRD.S78040","article-title":"Phosphate binders for the treatment of chronic kidney disease: role of iron oxyhydroxide","volume":"9","author":"Cernaro","year":"2016","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"7656","key":"2026032704271243600_lvaf222-B61","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1136\/bmj.39582.589433.BE","article-title":"Diagnosis and management of hypocalcaemia","volume":"336","author":"Cooper","year":"2008","journal-title":"BMJ"},{"key":"2026032704271243600_lvaf222-B62","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/cen.14798","article-title":"UK national chronic hypoparathyroidism audit","volume":"97(5)","author":"Kiam","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"2026032704271243600_lvaf222-B63","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1056\/NEJM197803162981101","article-title":"Treatment of hypoparathyroid patients with chlorthalidone","volume":"298","author":"Porter","year":"1978","journal-title":"N Engl J Med"},{"issue":"2","key":"2026032704271243600_lvaf222-B64","doi-asserted-by":"crossref","first-page":"655S","DOI":"10.3945\/ajcn.110.005728","article-title":"Defining the process of Dietary Reference Intakes: framework for the United States and Canada","volume":"94","author":"Atkinson","year":"2011","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"2026032704271243600_lvaf222-B65","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1210\/jc.2010-2704","article-title":"The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know","volume":"96","author":"Ross","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026032704271243600_lvaf222-B66","first-page":"e12420","article-title":"Disorders of Calcium Metabolism: Hypocalcemia and Hypercalcemia","volume":"13","author":"Tinawi","year":"2021","journal-title":"Cureus"},{"issue":"3-4","key":"2026032704271243600_lvaf222-B67","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ando.2020.02.003","article-title":"Cardiovascular consequences of parathyroid disorders in adults","volume":"82","author":"Bollerslev","year":"2021","journal-title":"Ann Endocrinol (Paris)"},{"issue":"9","key":"2026032704271243600_lvaf222-B68","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1210\/jc.2015-1855","article-title":"PTH(1-34) for Surgical Hypoparathyroidism: A Prospective, Open-Label Investigation of Efficacy and Quality of Life","volume":"100","author":"Santonati","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026032704271243600_lvaf222-B69","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1210\/jc.2017-01555","article-title":"PTH(1-34) for Surgical Hypoparathyroidism: A 2-Year Prospective, Open-Label Investigation of Efficacy and Quality of Life","volume":"103","author":"Palermo","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026032704271243600_lvaf222-B70","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1210\/jc.2017-01471","article-title":"Recombinant Human Parathyroid Hormone Effect on Health-Related Quality of Life in Adults With Chronic Hypoparathyroidism","volume":"103","author":"Vokes","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2026032704271243600_lvaf222-B71","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1210\/jc.2018-02430","article-title":"Quality of Life in Hypoparathyroidism Improves With rhPTH(1-84) Throughout 8 Years of Therapy","volume":"104","author":"Tabacco","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026032704271243600_lvaf222-B72","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s12020-016-1141-0","article-title":"Effects of parathyroid hormone rhPTH(1-84) on phosphate homeostasis and vitamin D metabolism in hypoparathyroidism: REPLACE phase 3 study","volume":"55","author":"Clarke","year":"2017","journal-title":"Endocrine"},{"issue":"6","key":"2026032704271243600_lvaf222-B73","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00223-010-9424-6","article-title":"Pharmacokinetics of teriparatide (rhPTH[1-34]) and calcium pharmacodynamics in postmenopausal women with osteoporosis","volume":"87","author":"Satterwhite","year":"2010","journal-title":"Calcif Tissue Int"},{"issue":"5","key":"2026032704271243600_lvaf222-B74","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.clinthera.2014.04.001","article-title":"Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study","volume":"36","author":"Clarke","year":"2014","journal-title":"Clin Ther"},{"issue":"10","key":"2026032704271243600_lvaf222-B75","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1002\/jbmr.1964","article-title":"PTH(1-84) replacement therapy in hypoparathyroidism: a randomized controlled trial on pharmacokinetic and dynamic effects after 6 months of treatment","volume":"28","author":"Sikjaer","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"7","key":"2026032704271243600_lvaf222-B76","doi-asserted-by":"crossref","first-page":"e10758","DOI":"10.1002\/jbm4.10758","article-title":"A Phase I Randomized Trial of Once-Daily Versus Twice-Daily Recombinant Human Parathyroid Hormone (1-84) for Hypoparathyroidism","volume":"7","author":"Ing","year":"2023","journal-title":"JBMR Plus"},{"issue":"9","key":"2026032704271243600_lvaf222-B77","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1210\/jc.2007-2552","article-title":"Effects of once versus twice-daily parathyroid hormone 1-34 therapy in children with hypoparathyroidism","volume":"93","author":"Winer","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2026032704271243600_lvaf222-B78","first-page":"3480","article-title":"A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidism","volume":"83","author":"Winer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026032704271243600_lvaf222-B79","first-page":"391","article-title":"Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism","volume":"97","author":"Winer","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026032704271243600_lvaf222-B80","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s12020-020-02577-x","article-title":"Chronic hypoparathyroidism and treatment with teriparatide","volume":"72","author":"Marcucci","year":"2021","journal-title":"Endocrine"},{"issue":"8","key":"2026032704271243600_lvaf222-B81","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1002\/jbmr.4016","article-title":"A Randomized Double-Blind Placebo-Controlled First-In-Human Phase 1 Trial of TransCon PTH in Healthy Adults","volume":"35","author":"Karpf","year":"2020","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2026032704271243600_lvaf222-B82","doi-asserted-by":"crossref","first-page":"e372","DOI":"10.1210\/clinem\/dgab577","article-title":"PaTH Forward: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of TransCon PTH in Adult Hypoparathyroidism","volume":"107","author":"Khan","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026032704271243600_lvaf222-B83","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/jbmr.4726","article-title":"Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial","volume":"38","author":"Khan","year":"2023","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2026032704271243600_lvaf222-B84","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1007\/s12325-024-02843-8","article-title":"Palopegteriparatide Treatment Improves Renal Function in Adults with Chronic Hypoparathyroidism: 1-Year Results from the Phase 3 PaTHway Trial","volume":"41","author":"Rejnmark","year":"2024","journal-title":"Adv Ther"},{"issue":"9","key":"2026032704271243600_lvaf222-B85","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1210\/clinem\/dgae121","article-title":"An Open-label Phase 2 Study of Eneboparatide, a Novel PTH Receptor 1 Agonist, in Hypoparathyroidism","volume":"109","author":"Takacs","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"13","key":"2026032704271243600_lvaf222-B86","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1056\/NEJMc2302708","article-title":"Efficacy and Safety of Encaleret in Autosomal Dominant Hypocalcemia Type 1","volume":"389","author":"Gafni","year":"2023","journal-title":"N Engl J Med"},{"issue":"2","key":"2026032704271243600_lvaf222-B87","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1530\/EJE-15-0625","article-title":"ESE guidelines, why and how","volume":"173","author":"Dekkers","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"2026032704271243600_lvaf222-B88","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jclinepi.2013.02.003","article-title":"GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength","volume":"66","author":"Andrews","year":"2013","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"2026032704271243600_lvaf222-B89","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1002\/jbmr.4716","article-title":"Management of Hypoparathyroidism","volume":"37","author":"Khan","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2026032704271243600_lvaf222-B90","doi-asserted-by":"crossref","first-page":"ziad010","DOI":"10.1093\/jbmrpl\/ziad010","article-title":"Open-label extension of a randomized trial investigating safety and efficacy of rhPTH(1-84) in hypoparathyroidism","volume":"8","author":"Khan","year":"2024","journal-title":"JBMR Plus"},{"issue":"11","key":"2026032704271243600_lvaf222-B91","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1210\/jc.2019-01010","article-title":"Safety and Efficacy of 5 Years of Treatment With Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism","volume":"104","author":"Mannstadt","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026032704271243600_lvaf222-B92","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00423-018-1693-y","article-title":"Patients\u2019 views about parathyroid transplantation for post-thyroidectomy hypoparathyroidism","volume":"403","author":"Stevenson","year":"2018","journal-title":"Langenbecks Arch Surg"},{"issue":"9","key":"2026032704271243600_lvaf222-B93","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1007\/s00268-014-2571-6","article-title":"Factors predicting post-thyroidectomy hypoparathyroidism recovery","volume":"38","author":"Al-Dhahri","year":"2014","journal-title":"World J Surg"},{"issue":"3","key":"2026032704271243600_lvaf222-B94","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-21-0130","article-title":"Parathyroid hormone of &gt;\/=1.6\u2005pmol\/L at 6 months is associated with recovery in \u2018long-term\u2019 post-surgical hypoparathyroidism","volume":"11","author":"Arshad","year":"2022","journal-title":"Eur Thyroid J"},{"issue":"2","key":"2026032704271243600_lvaf222-B95","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s12020-019-02014-8","article-title":"Prevalence and risk factors for hypoparathyroidism following total thyroidectomy in Spain: a multicentric and nation-wide retrospective analysis","volume":"66","author":"Diez","year":"2019","journal-title":"Endocrine"},{"issue":"11","key":"2026032704271243600_lvaf222-B96","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11113202","article-title":"How Long Does It Take to Regain Normocalcaemia in the Event of Postsurgical Hypoparathyroidism? A Detailed Time Course Analysis","volume":"11","author":"Guglielmetti","year":"2022","journal-title":"J Clin Med"},{"issue":"2","key":"2026032704271243600_lvaf222-B97","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.otorri.2012.09.001","article-title":"Hypocalcaemia after total thyroidectomy: incidence, control and treatment","volume":"64","author":"Herranz Gonzalez-Botas","year":"2013","journal-title":"Acta Otorrinolaringol Esp"},{"issue":"3","key":"2026032704271243600_lvaf222-B98","doi-asserted-by":"crossref","first-page":"e0174088","DOI":"10.1371\/journal.pone.0174088","article-title":"Parathyroid score can predict the duration of required calcium supplementation after total thyroidectomy","volume":"12","author":"Kim","year":"2017","journal-title":"PLoS One"},{"issue":"6-7","key":"2026032704271243600_lvaf222-B99","first-page":"493","article-title":"[The parathyroid risk in thyroid surgery. Argument against the early postoperative prescription of vitamin D. Experience with 729 thyroidectomies in 1988]","volume":"116","author":"Proye","year":"1990","journal-title":"Chirurgie"},{"issue":"5","key":"2026032704271243600_lvaf222-B100","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/(SICI)1097-0347(199708)19:5<378::AID-HED3>3.0.CO;2-X","article-title":"Total thyroidectomy for Graves\u2019 disease","volume":"19","author":"Razack","year":"1997","journal-title":"Head Neck"},{"issue":"2","key":"2026032704271243600_lvaf222-B101","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jss.2015.04.059","article-title":"Hypoparathyroidism after total thyroidectomy: incidence and resolution","volume":"197","author":"Ritter","year":"2015","journal-title":"J Surg Res"},{"issue":"1","key":"2026032704271243600_lvaf222-B102","doi-asserted-by":"crossref","first-page":"10","DOI":"10.21037\/gs-20-486","article-title":"Surgical strategy when identifying less than four parathyroid glands during total thyroidectomy: a retrospective cohort study","volume":"10","author":"Xing","year":"2021","journal-title":"Gland Surg"},{"key":"2026032704271243600_lvaf222-B103","first-page":"e20230406","article-title":"The effects of adequate dietary calcium intake in patients with hypoparathyroidism non-adherent to treatment: a prospective randomized controlled trial","volume":"69(11)","author":"Canat","year":"(1992), 2023","journal-title":"Rev Assoc Med Bras"},{"issue":"7","key":"2026032704271243600_lvaf222-B104","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/jbmr.4564","article-title":"Calcium Citrate Versus Calcium Carbonate in the Management of Chronic Hypoparathyroidism: A Randomized, Double-Blind, Crossover Clinical Trial","volume":"37","author":"Naciu","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2026032704271243600_lvaf222-B105","doi-asserted-by":"crossref","first-page":"e10586","DOI":"10.1002\/jbm4.10586","article-title":"The Influence of Conventional Treatment on Symptoms and Complaints in Patients With Chronic Postsurgical Hypoparathyroidism","volume":"6","author":"Stamm","year":"2022","journal-title":"JBMR Plus"},{"issue":"5","key":"2026032704271243600_lvaf222-B106","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1210\/jc.2016-3712","article-title":"Hypoparathyroidism: Less Severe Hypocalcemia With Treatment With Vitamin D2 Compared With Calcitriol","volume":"102","author":"Streeten","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2026032704271243600_lvaf222-B107","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1007\/s12325-022-02198-y","article-title":"Lower Risk of Cardiovascular Events in Adult Patients with Chronic Hypoparathyroidism Treated with rhPTH(1-84): A Retrospective Cohort Study","volume":"39","author":"Ayodele","year":"2022","journal-title":"Adv Ther"},{"issue":"9","key":"2026032704271243600_lvaf222-B108","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1007\/s40618-022-01800-y","article-title":"Multicenter retro-prospective observational study on chronic hypoparathyroidism and rhPTH (1-84) treatment","volume":"45","author":"Marcucci","year":"2022","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"2026032704271243600_lvaf222-B109","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/cen.14813","article-title":"The risk of chronic kidney disease development in adult patients with chronic hypoparathyroidism treated with rhPTH(1-84): A retrospective cohort study","volume":"98","author":"Rejnmark","year":"2023","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"2026032704271243600_lvaf222-B110","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.eprac.2023.12.001","article-title":"Extended Treatment With Recombinant Human Parathyroid Hormone (1-84) in Adult Patients With Chronic Hypoparathyroidism","volume":"30","author":"Rubin","year":"2024","journal-title":"Endocr Pract"},{"issue":"6","key":"2026032704271243600_lvaf222-B111","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s00198-014-2677-6","article-title":"Effects of PTH(1-84) therapy on muscle function and quality of life in hypoparathyroidism: results from a randomized controlled trial","volume":"25","author":"Sikjaer","year":"2014","journal-title":"Osteoporos Int"},{"issue":"5","key":"2026032704271243600_lvaf222-B112","doi-asserted-by":"crossref","first-page":"bvad043","DOI":"10.1210\/jendso\/bvad043","article-title":"Long-Term Safety and Efficacy of Recombinant Human Parathyroid Hormone (1-84) in Adults With Chronic Hypoparathyroidism","volume":"7","author":"Watts","year":"2023","journal-title":"J Endocr Soc"},{"issue":"11","key":"2026032704271243600_lvaf222-B113","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1007\/s00198-009-1149-x","article-title":"Therapy of hypoparathyroidism with intact parathyroid hormone","volume":"21","author":"Rubin","year":"2010","journal-title":"Osteoporos Int"},{"issue":"10","key":"2026032704271243600_lvaf222-B114","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/jbmr.3480","article-title":"Hypocitraturia Is an Untoward Side Effect of Synthetic Human Parathyroid Hormone (hPTH) 1-34 Therapy in Hypoparathyroidism That May Increase Renal Morbidity","volume":"33","author":"Gafni","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2026032704271243600_lvaf222-B115","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/jbmr.4274","article-title":"Safety and Efficacy of Oral Human Parathyroid Hormone (1-34) in Hypoparathyroidism: An Open-Label Study","volume":"36","author":"Ish-Shalom","year":"2021","journal-title":"J Bone Miner Res"},{"issue":"9","key":"2026032704271243600_lvaf222-B116","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1210\/jc.2002-021736","article-title":"Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium","volume":"88","author":"Winer","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026032704271243600_lvaf222-B117","first-page":"431","article-title":"Parathyroid Allotransplant With a New Technique: A Prospective Clinical Trial","volume":"14","author":"Aysan","year":"2016","journal-title":"Exp Clin Transplant"},{"issue":"Suppl 1","key":"2026032704271243600_lvaf222-B118","first-page":"233","article-title":"The Challenge of Preoperative Panel Reactive Antibody Positivity in Parathyroid Transplantation","volume":"22","author":"Goncu","year":"2024","journal-title":"Exp Clin Transplant"},{"issue":"6","key":"2026032704271243600_lvaf222-B119","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/01.tp.0000258601.17505.9d","article-title":"Allotransplantation of cultured parathyroid progenitor cells without immunosuppression: clinical results","volume":"83","author":"Nawrot","year":"2007","journal-title":"Transplantation"},{"issue":"9","key":"2026032704271243600_lvaf222-B120","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1210\/jc.2012-1429","article-title":"The importance of measuring ionized calcium in characterizing calcium status and diagnosing primary hyperparathyroidism","volume":"97","author":"Ong","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026032704271243600_lvaf222-B121","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1056\/NEJMcp0803050","article-title":"Clinical practice. Hypoparathyroidism","volume":"359","author":"Shoback","year":"2008","journal-title":"N Engl J Med"},{"issue":"12","key":"2026032704271243600_lvaf222-B122","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1002\/jbmr.4691","article-title":"Evaluation and Management of Hypoparathyroidism Summary Statement and Guidelines from the Second International Workshop","volume":"37","author":"Khan","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2026032704271243600_lvaf222-B123","doi-asserted-by":"crossref","first-page":"821","DOI":"10.4103\/2230-8210.141365","article-title":"Estimation of magnesium in patients with functional hypoparathyroidism","volume":"18","author":"Kannan","year":"2014","journal-title":"Indian J Endocrinol Metab"},{"issue":"1","key":"2026032704271243600_lvaf222-B124","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s12020-024-03807-2","article-title":"Quality of life in patients with hypoparathyroidism receiving standard treatment: an updated systematic review","volume":"85","author":"Buttner","year":"2024","journal-title":"Endocrine"},{"issue":"12","key":"2026032704271243600_lvaf222-B125","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1210\/jc.2012-1808","article-title":"Long-term follow-up of patients with hypoparathyroidism","volume":"97","author":"Mitchell","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026032704271243600_lvaf222-B126","doi-asserted-by":"crossref","first-page":"452","DOI":"10.2215\/CJN.12511213","article-title":"Association of urinary calcium excretion with serum calcium and vitamin D levels","volume":"10","author":"Rathod","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026032704271243600_lvaf222-B127","doi-asserted-by":"crossref","first-page":"1244647","DOI":"10.3389\/fendo.2023.1244647","article-title":"Renal complications in chronic hypoparathyroidism - a systematic cross-sectional assessment","volume":"14","author":"Gronemeyer","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026032704271243600_lvaf222-B128","doi-asserted-by":"crossref","first-page":"800119","DOI":"10.3389\/fendo.2022.800119","article-title":"The Russian Registry of Chronic Hypoparathyroidism","volume":"13","author":"Kovaleva","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"2026032704271243600_lvaf222-B129","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1590\/2359-3997000000221","article-title":"Hypoparathyroidism and pseudohypoparathyroidism: etiology, laboratory features and complications","volume":"60","author":"Lopes","year":"2016","journal-title":"Arch Endocrinol Metab"},{"issue":"4","key":"2026032704271243600_lvaf222-B130","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz319","article-title":"Nephrocalcinosis, Renal Dysfunction, and Calculi in Patients With Primary Hypoparathyroidism on Long-Term Conventional Therapy","volume":"105","author":"Saha","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2026032704271243600_lvaf222-B131","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1007\/s12020-024-03765-9","article-title":"Long-term complications of permanent hypoparathyroidism in adults: prevalence and associated factors","volume":"84","author":"Cherchir","year":"2024","journal-title":"Endocrine"},{"issue":"2","key":"2026032704271243600_lvaf222-B132","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s12020-021-02629-w","article-title":"Canadian national hypoparathyroidism registry: an overview of hypoparathyroidism in Canada","volume":"72","author":"Khan","year":"2021","journal-title":"Endocrine"},{"issue":"3","key":"2026032704271243600_lvaf222-B133","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s40618-021-01686-2","article-title":"Renal complications and quality of life in postsurgical hypoparathyroidism: a case-control study","volume":"45","author":"Mazoni","year":"2022","journal-title":"J Endocrinol Invest"},{"issue":"8","key":"2026032704271243600_lvaf222-B134","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.2215\/CJN.11321210","article-title":"Pathophysiology-based treatment of idiopathic calcium kidney stones","volume":"6","author":"Coe","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"2026032704271243600_lvaf222-B135","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00240-012-0524-9","article-title":"A proposed method for approximate estimates of the ion-activity products of calcium oxalate and calcium phosphate in spot-urine samples or in urine samples collected during less well defined periods of time","volume":"41","author":"Tiselius","year":"2013","journal-title":"Urolithiasis"},{"issue":"1","key":"2026032704271243600_lvaf222-B136","first-page":"91","volume":"44","author":"Tiselius","year":"2016","journal-title":"Metabolic risk-evaluation and prevention of recurrence in stone disease: does it make sense?"},{"issue":"12","key":"2026032704271243600_lvaf222-B137","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1210\/jcem.85.12.7035","article-title":"Comparison of hypocalcemic hypercalciuria between patients with idiopathic hypoparathyroidism and those with gain-of-function mutations in the calcium-sensing receptor: is it possible to differentiate the two disorders?","volume":"85","author":"Yamamoto","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026032704271243600_lvaf222-B138","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s40618-024-02496-y","article-title":"Management of autosomal dominant hypocalcemia type 1: Literature review and clinical practice recommendations","volume":"48","author":"De Coster","year":"2025","journal-title":"J Endocrinol Invest"},{"issue":"6 Suppl","key":"2026032704271243600_lvaf222-B139","first-page":"29","article-title":"Hyperphosphatemia: effects on bone metabolism and cardiovascular risk","volume":"30","author":"Caudarella","year":"2007","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"2026032704271243600_lvaf222-B140","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/ndt\/gft400","article-title":"Magnesium modulates parathyroid hormone secretion and upregulates parathyroid receptor expression at moderately low calcium concentration","volume":"29","author":"Rodriguez-Ortiz","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"2026032704271243600_lvaf222-B141","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1515\/cclm-2023-0537","article-title":"Improving diagnosis and treatment of hypomagnesemia","volume":"62","author":"Salinas","year":"2024","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"2026032704271243600_lvaf222-B142","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1210\/er.2018-00126","article-title":"Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions","volume":"40","author":"Bouillon","year":"2019","journal-title":"Endocr Rev"},{"key":"2026032704271243600_lvaf222-B143","first-page":"765629","article-title":"Therapy of hypoparathyroidism by replacement with parathyroid hormone","volume":"2014","author":"Rejnmark","year":"2014","journal-title":"Scientifica (Cairo)"},{"issue":"5","key":"2026032704271243600_lvaf222-B144","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1210\/endrev\/bnae009","article-title":"Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows","volume":"45","author":"Giustina","year":"2024","journal-title":"Endocr Rev"},{"issue":"1","key":"2026032704271243600_lvaf222-B145","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2174\/187152013804487434","article-title":"Role of calcium, vitamin D, and the extrarenal vitamin D hydroxylases in carcinogenesis","volume":"13","author":"Hobaus","year":"2013","journal-title":"Anticancer Agents Med Chem"},{"issue":"Suppl 1","key":"2026032704271243600_lvaf222-B146","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4158\/EP10302.RA","article-title":"Medical management of postsurgical hypoparathyroidism","volume":"17","author":"Khan","year":"2011","journal-title":"Endocr Pract"},{"issue":"6","key":"2026032704271243600_lvaf222-B147","doi-asserted-by":"crossref","first-page":"X1","DOI":"10.1530\/EC-16-0056a","article-title":"SOCIETY FOR ENDOCRINOLOGY EMERGENCY ENDOCRINE GUIDANCE: Emergency management of acute hypocalcaemia in adult patients","volume":"8","author":"Turner","year":"2019","journal-title":"Endocr Connect"},{"issue":"21","key":"2026032704271243600_lvaf222-B148","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1093\/hmg\/ddq342","article-title":"Common variants in the calcium-sensing receptor gene are associated with total serum calcium levels","volume":"19","author":"O'Seaghdha","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"5","key":"2026032704271243600_lvaf222-B149","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1210\/jcem-31-5-595","article-title":"Total urinary hydroxyproline excretion after administration of Vitamin D to patients with hypoparathyroidism","volume":"31","author":"Mautalen","year":"1970","journal-title":"J Clin Endocrinol Metab"},{"issue":"8002","key":"2026032704271243600_lvaf222-B150","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0140-6736(77)91077-7","article-title":"1,25-dihydroxycholecalciferol in hypoparathyroidism","volume":"1","author":"Davies","year":"1977","journal-title":"Lancet"},{"issue":"5","key":"2026032704271243600_lvaf222-B151","first-page":"167S","article-title":"Treatment of hypoparathyroidism with 1,25-dihydroxycholecalciferol","author":"Hill","year":"1976","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"2026032704271243600_lvaf222-B152","first-page":"191s","article-title":"Physiological and therapeutic differences between vitamin D, its metabolites and analogues","author":"Kanis","year":"1977","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6053","key":"2026032704271243600_lvaf222-B153","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/bmj.1.6053.78","article-title":"Rate of reversal of hypercalcaemia and hypercalciuria induced by vitamin D and its 1alpha-hydroxylated derivatives","volume":"1","author":"Kanis","year":"1977","journal-title":"Br Med J"},{"issue":"7","key":"2026032704271243600_lvaf222-B154","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1210\/clinem\/dgab114","article-title":"Alfacalcidol vs Calcitriol in the Management of Patient With Hypoparathyroidism: A Randomized Controlled Trial","volume":"106","author":"Saha","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026032704271243600_lvaf222-B155","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1210\/jcem-55-2-238","article-title":"Comparative efficacy of various vitamin D metabolites in the treatment of various types of hypoparathyroidism","volume":"55","author":"Okano","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026032704271243600_lvaf222-B156","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1046\/j.1525-139X.2002.00086.x","article-title":"Comparative review of the pharmacokinetics of vitamin D analogues","volume":"15","author":"Bailie","year":"2002","journal-title":"Semin Dial"},{"issue":"2","key":"2026032704271243600_lvaf222-B157","first-page":"239","article-title":"Pharmacokinetics and biologic effects of calcitriol in normal humans","volume":"105","author":"Levine","year":"1985","journal-title":"J Lab Clin Med"},{"issue":"10","key":"2026032704271243600_lvaf222-B158","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1359\/jbmr.1999.14.10.1789","article-title":"No difference in intestinal strontium absorption after an oral or an intravenous 1,25(OH)2D3 bolus in normal subjects. For the European Study Group on Vitamin D in children with renal failure","volume":"14","author":"Bianchi","year":"1999","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2026032704271243600_lvaf222-B159","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1172\/JCI108424","article-title":"Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man","volume":"57","author":"Brickman","year":"1976","journal-title":"J Clin Invest"},{"issue":"1","key":"2026032704271243600_lvaf222-B160","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5603\/EP.a2023.0008","article-title":"Clinical efficacy and safety of use of alfacalcidol and calcitriol in daily endocrinological practice","volume":"74","author":"Stuss","year":"2023","journal-title":"Endokrynol Pol"},{"issue":"6","key":"2026032704271243600_lvaf222-B161","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1210\/jc.2015-3910","article-title":"Management of Hypoparathyroidism: Present and Future","volume":"101","author":"Bilezikian","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026032704271243600_lvaf222-B162","first-page":"479","article-title":"Circulating 1 alpha,25-dihydroxyvitamin D levels after a single dose of 1 alpha,25-dihydroxyvitamin D3 or 1 alpha-hydroxyvitamin D3 in normal men","volume":"2","author":"Seino","year":"1987","journal-title":"Bone Miner"},{"issue":"6","key":"2026032704271243600_lvaf222-B163","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/cen.13955","article-title":"Is calcium supplementation always needed in patients with hypoparathyroidism?","volume":"90","author":"Al-Sharefi","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2026032704271243600_lvaf222-B164","first-page":"881","article-title":"Calcium absorption as a function of calcium intake","volume":"85","author":"Heaney","year":"1975","journal-title":"J Lab Clin Med"},{"issue":"3","key":"2026032704271243600_lvaf222-B165","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/jbmr.5650030303","article-title":"Dose dependency of calcium absorption: a comparison of calcium carbonate and calcium citrate","volume":"3","author":"Harvey","year":"1988","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2026032704271243600_lvaf222-B166","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1177\/0115426507022003286","article-title":"Calcium supplementation in clinical practice: a review of forms, doses, and indications","volume":"22","author":"Straub","year":"2007","journal-title":"Nutr Clin Pract"},{"issue":"7","key":"2026032704271243600_lvaf222-B167","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s40265-013-0054-y","article-title":"Hyperphosphataemia: treatment options","volume":"73","author":"Malberti","year":"2013","journal-title":"Drugs"},{"issue":"2","key":"2026032704271243600_lvaf222-B168","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/ajcn\/41.2.254","article-title":"The effect of milk supplements on calcium metabolism, bone metabolism and calcium balance","volume":"41","author":"Recker","year":"1985","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"2026032704271243600_lvaf222-B169","doi-asserted-by":"crossref","first-page":"244","DOI":"10.2174\/1389200219666181026160242","article-title":"Iron and Vitamin D\/Calcium Deficiency after Gastric Bypass: Mechanisms Involved and Strategies to Improve Oral Supplement Disposition","volume":"20","author":"Mangan","year":"2019","journal-title":"Curr Drug Metab"},{"key":"2026032704271243600_lvaf222-B170","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jsbmb.2016.12.012","article-title":"Vitamin D and intestinal calcium transport after bariatric surgery","volume":"173","author":"Schafer","year":"2017","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3","key":"2026032704271243600_lvaf222-B171","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2215\/CJN.08000520","article-title":"Pathophysiology and Treatment of Enteric Hyperoxaluria","volume":"16","author":"Witting","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"2026032704271243600_lvaf222-B172","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1089\/thy.2010.0296","article-title":"Absorption of levothyroxine when coadministered with various calcium formulations","volume":"21","author":"Zamfirescu","year":"2011","journal-title":"Thyroid"},{"issue":"12","key":"2026032704271243600_lvaf222-B173","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1002\/jbmr.4676","article-title":"Parathyroid Hormone Therapy for Managing Chronic Hypoparathyroidism: A Systematic Review and Meta-Analysis","volume":"37","author":"Yao","year":"2022","journal-title":"J Bone Miner Res"},{"key":"2026032704271243600_lvaf222-B174","article-title":"Efficacy and Safety of TransCon PTH in Adults with Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway Trial","author":"Clarke","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026032704271243600_lvaf222-B175","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s13023-024-03155-4","article-title":"Economic burden of patients with post-surgical chronic and transient hypoparathyroidism in the United States examined using insurance claims data","volume":"19","author":"Deering","year":"2024","journal-title":"Orphanet J Rare Dis"},{"issue":"12","key":"2026032704271243600_lvaf222-B176","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1002\/jbmr.4675","article-title":"Epidemiology and Financial Burden of Adult Chronic Hypoparathyroidism","volume":"37","author":"Bjornsdottir","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2026032704271243600_lvaf222-B177","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/cen.14128","article-title":"Burden of illness in not adequately controlled chronic hypoparathyroidism: Findings from a 13-country patient and caregiver survey","volume":"92","author":"Siggelkow","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"2026032704271243600_lvaf222-B178","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.1007\/s12325-022-02292-1","article-title":"Five-Year Estimated Glomerular Filtration Rate in Adults with Chronic Hypoparathyroidism Treated with rhPTH(1-84): A Retrospective Cohort Study","volume":"39","author":"Ayodele","year":"2022","journal-title":"Adv Ther"},{"issue":"6","key":"2026032704271243600_lvaf222-B179","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1007\/s12325-024-02843-8","article-title":"Palopegteriparatide Treatment Improves Renal Function in Adults with Chronic Hypoparathyroidism: 1-Year Results from the Phase 3 PaTHway Trial","volume":"41","author":"Rejnmark","year":"2024","journal-title":"Adv Ther"},{"issue":"4","key":"2026032704271243600_lvaf222-B180","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1007\/s12325-021-01658-1","article-title":"Risk of Chronic Kidney Disease and Estimated Glomerular Filtration Rate Decline in Patients with Chronic Hypoparathyroidism: A Retrospective Cohort Study","volume":"38","author":"Gosmanova","year":"2021","journal-title":"Adv Ther"},{"issue":"7","key":"2026032704271243600_lvaf222-B181","first-page":"2366","article-title":"Calcium-regulated renal calcium handling in healthy men: relationship to sodium handling","volume":"83","author":"el-Hajj Fuleihan","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2026032704271243600_lvaf222-B182","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1017\/S0007114509990195","article-title":"Acute effects of calcium carbonate, calcium citrate and potassium citrate on markers of calcium and bone metabolism in young women","volume":"102","author":"Karp","year":"2009","journal-title":"Br J Nutr"},{"issue":"4","key":"2026032704271243600_lvaf222-B183","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13041114","article-title":"Urological Guidelines for Kidney Stones: Overview and Comprehensive Update","volume":"13","author":"Akram","year":"2024","journal-title":"J Clin Med"},{"issue":"2","key":"2026032704271243600_lvaf222-B184","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000166496","article-title":"Urinary calcium excretion at extremes of sodium intake in normal man","volume":"1","author":"McCarron","year":"1981","journal-title":"Am J Nephrol"},{"issue":"4","key":"2026032704271243600_lvaf222-B185","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1055\/s-2007-999516","article-title":"Use of thiazide diuretics to reduce the hypercalciuria of hypoparathyroidism during pregnancy","volume":"7","author":"Kurzel","year":"1990","journal-title":"Am J Perinatol"},{"issue":"1","key":"2026032704271243600_lvaf222-B186","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF02395204","article-title":"Effect of bendrofluazide on calcium reabsorption in hypoparathyroidism","volume":"27","author":"Newman","year":"1984","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"2026032704271243600_lvaf222-B187","doi-asserted-by":"crossref","first-page":"557","DOI":"10.7326\/0003-4819-77-4-557","article-title":"Thiazide-induced hypercalcemia in vitamin D-treated hypoparathyroidism","volume":"77","author":"Parfitt","year":"1972","journal-title":"Ann Intern Med"},{"issue":"2","key":"2026032704271243600_lvaf222-B188","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/archpedi.1986.02140160057032","article-title":"Hypercalciuria associated with long-term administration of calcitriol (1,25-dihydroxyvitamin D3). Action of hydrochlorothiazide","volume":"140","author":"Santos","year":"1986","journal-title":"Am J Dis Child"},{"issue":"1","key":"2026032704271243600_lvaf222-B189","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/14656566.2019.1685979","article-title":"Established and recent developments in the pharmacological management of urolithiasis: an overview of the current treatment armamentarium","volume":"21","author":"Abou Chakra","year":"2020","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"2026032704271243600_lvaf222-B190","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0002-9343(81)90215-1","article-title":"Prevention of calcium nephrolithiasis with low-dose thiazide, amiloride and allopurinol","volume":"71","author":"Maschio","year":"1981","journal-title":"Am J Med"},{"issue":"11","key":"2026032704271243600_lvaf222-B191","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ndt\/17.suppl_11.16","article-title":"Hyperphosphataemia as a cardiovascular risk factor \u2013 how to manage the problem","volume":"17","author":"Cannata-Andia","year":"2002","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"2026032704271243600_lvaf222-B192","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/ki.2014.425","article-title":"Revisiting KDIGO clinical practice guideline on chronic kidney disease-mineral and bone disorder: a commentary from a Kidney Disease: Improving Global Outcomes controversies conference","volume":"87","author":"Ketteler","year":"2015","journal-title":"Kidney Int"},{"issue":"17","key":"2026032704271243600_lvaf222-B193","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMc066308","article-title":"Proton-pump inhibitors and hypomagnesemic hypoparathyroidism","volume":"355","author":"Epstein","year":"2006","journal-title":"N Engl J Med"},{"issue":"11","key":"2026032704271243600_lvaf222-B194","doi-asserted-by":"crossref","first-page":"E2090","DOI":"10.1210\/jc.2012-2301","article-title":"Magnesium supplementation does not affect blood calcium level in treated hypoparathyroid patients","volume":"97","author":"Lubi","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026032704271243600_lvaf222-B195","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2125.1993.tb04153.x","article-title":"A comparison of the potassium and magnesium-sparing properties of amiloride and spironolactone in diuretic-treated normal subjects","volume":"35","author":"Murdoch","year":"1993","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"2026032704271243600_lvaf222-B196","doi-asserted-by":"crossref","DOI":"10.3390\/nu10091202","article-title":"Challenges in the Diagnosis of Magnesium Status","volume":"10","author":"Workinger","year":"2018","journal-title":"Nutrients"},{"issue":"5","key":"2026032704271243600_lvaf222-B197","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1210\/jcem-73-5-1067","article-title":"Effect of experimental human magnesium depletion on parathyroid hormone secretion and 1,25-dihydroxyvitamin D metabolism","volume":"73","author":"Fatemi","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026032704271243600_lvaf222-B198","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/00365519409086506","article-title":"The magnesium loading test: reference values in healthy subjects","volume":"54","author":"Gullestad","year":"1994","journal-title":"Scand J Clin Lab Invest"},{"issue":"1","key":"2026032704271243600_lvaf222-B199","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1291\/hypres.18.39","article-title":"Systemic magnesium deficiency disclosed by magnesium loading test in patients with essential hypertension","volume":"18","author":"Ozono","year":"1995","journal-title":"Hypertens Res"},{"key":"2026032704271243600_lvaf222-B200","volume-title":"Dietary Reference Intakes for Calcium and Vitamin D","author":"Ross","year":"2011"},{"issue":"5","key":"2026032704271243600_lvaf222-B201","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1530\/EC-20-0067","article-title":"Serum PTH is not a good marker for defining a threshold for vitamin D deficiency","volume":"9","author":"Jorde","year":"2020","journal-title":"Endocr Connect"},{"issue":"4","key":"2026032704271243600_lvaf222-B202","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1210\/edrv.22.4.0437","article-title":"Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications","volume":"22","author":"Lips","year":"2001","journal-title":"Endocr Rev"},{"key":"2026032704271243600_lvaf222-B203","doi-asserted-by":"crossref","first-page":"105854","DOI":"10.1016\/j.cct.2019.105854","article-title":"Serum 25-hydroxyvitamin D in the VITamin D and OmegA-3 TriaL (VITAL): Clinical and demographic characteristics associated with baseline and change with randomized vitamin D treatment","volume":"87","author":"Luttmann-Gibson","year":"2019","journal-title":"Contemp Clin Trials"},{"issue":"3","key":"2026032704271243600_lvaf222-B204","doi-asserted-by":"crossref","DOI":"10.3390\/nu16030391","article-title":"Vitamin D Supplementation: A Review of the Evidence Arguing for a Daily Dose of 2000 International Units (50 microg) of Vitamin D for Adults in the General Population","volume":"16","author":"Pludowski","year":"2024","journal-title":"Nutrients"},{"issue":"1","key":"2026032704271243600_lvaf222-B205","doi-asserted-by":"crossref","DOI":"10.3390\/nu9010030","article-title":"Effect of Two Different Multimicronutrient Supplements on Vitamin D Status in Women of Childbearing Age: A Randomized Trial","volume":"9","author":"Pilz","year":"2017","journal-title":"Nutrients"},{"issue":"5","key":"2026032704271243600_lvaf222-B206","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.3945\/ajcn.2008.27334","article-title":"Estimation of the dietary requirement for vitamin D in free-living adults &gt;=64 y of age","volume":"89","author":"Cashman","year":"2009","journal-title":"Am J Clin Nutr"},{"issue":"12","key":"2026032704271243600_lvaf222-B207","doi-asserted-by":"crossref","first-page":"e10567","DOI":"10.1002\/jbm4.10567","article-title":"Vitamin D: Bolus Is Bogus-A Narrative Review","volume":"5","author":"Mazess","year":"2021","journal-title":"JBMR Plus"},{"issue":"4","key":"2026032704271243600_lvaf222-B208","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1007\/s00394-023-03124-w","article-title":"Long-term supplementation with 3200 to 4000\u2005IU of vitamin D daily and adverse events: a systematic review and meta-analysis of randomized controlled trials","volume":"62","author":"Zittermann","year":"2023","journal-title":"Eur J Nutr"},{"issue":"11","key":"2026032704271243600_lvaf222-B209","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1210\/jc.2013-2937","article-title":"Recovery of parathyroid hormone secretion and function in postoperative hypoparathyroidism: a case series","volume":"98","author":"Cusano","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026032704271243600_lvaf222-B210","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/archsurg.140.4.374","article-title":"Surgical treatment of hyperparathyroidism in patients with multiple endocrine neoplasia type 1","volume":"140","author":"Lambert","year":"2005","journal-title":"Arch Surg"},{"issue":"7","key":"2026032704271243600_lvaf222-B211","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1089\/thy.2014.0500","article-title":"Recovery from Permanent Hypoparathyroidism After Total Thyroidectomy","volume":"25","author":"Kim","year":"2015","journal-title":"Thyroid"},{"issue":"3","key":"2026032704271243600_lvaf222-B212","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1067\/msy.2000.107102","article-title":"Parathyroid-induced angiogenesis is VEGF-dependent","volume":"128","author":"Carter","year":"2000","journal-title":"Surgery"},{"issue":"11","key":"2026032704271243600_lvaf222-B213","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1365-2362.2008.02033.x","article-title":"Parathyroid hormone stimulates the endothelial expression of vascular endothelial growth factor","volume":"38","author":"Rashid","year":"2008","journal-title":"Eur J Clin Invest"},{"issue":"3","key":"2026032704271243600_lvaf222-B214","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.bone.2011.05.003","article-title":"Effects of intermittent parathyroid hormone treatment on osteoprogenitor cells in postmenopausal women","volume":"49","author":"Drake","year":"2011","journal-title":"Bone"},{"issue":"5","key":"2026032704271243600_lvaf222-B215","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1210\/endo-117-5-2114","article-title":"1,25-Dihydroxyvitamin D3 suppresses parathyroid hormone secretion from bovine parathyroid cells in tissue culture","volume":"117","author":"Cantley","year":"1985","journal-title":"Endocrinology"},{"issue":"2","key":"2026032704271243600_lvaf222-B216","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1530\/eje.0.1460215","article-title":"Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D","volume":"146","author":"Arlt","year":"2002","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2026032704271243600_lvaf222-B217","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4158\/EP.11.1.37","article-title":"Urinary calcium excretion in primary hyperparathyroidism: relationship to 25-hydroxyvitamin d status","volume":"11","author":"Bussey","year":"2005","journal-title":"Endocr Pract"},{"key":"2026032704271243600_lvaf222-B218","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/1471-2369-13-160","article-title":"Effects of a high-sodium diet on renal tubule Ca2+ transporter and claudin expression in Wistar-Kyoto rats","volume":"13","author":"Yatabe","year":"2012","journal-title":"BMC Nephrol"},{"issue":"9","key":"2026032704271243600_lvaf222-B219","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/jn\/123.9.1615","article-title":"The nature and significance of the relationship between urinary sodium and urinary calcium in women","volume":"123","author":"Nordin","year":"1993","journal-title":"J Nutr"},{"key":"2026032704271243600_lvaf222-B220","volume-title":"in Guideline: Sodium Intake for Adults and Children","author":"WHO","year":"2012"},{"issue":"1","key":"2026032704271243600_lvaf222-B221","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00394-015-1067-y","article-title":"Estimation of salt intake assessed by urinary excretion of sodium over 24\u2005h in Spanish subjects aged 7-11 years","volume":"56","author":"Aparicio","year":"2017","journal-title":"Eur J Nutr"},{"issue":"2","key":"2026032704271243600_lvaf222-B222","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1523-1755.2004.00386.x","article-title":"The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance","volume":"65","author":"Abate","year":"2004","journal-title":"Kidney Int"},{"issue":"4","key":"2026032704271243600_lvaf222-B223","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/JU.0000000000002331","article-title":"Incidence of Kidney Stones in the United States: The Continuous National Health and Nutrition Examination Survey","volume":"207","author":"Hill","year":"2022","journal-title":"J Urol"},{"issue":"1","key":"2026032704271243600_lvaf222-B224","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.eururo.2013.03.026","article-title":"Diabetic severity and risk of kidney stone disease","volume":"65","author":"Weinberg","year":"2014","journal-title":"Eur Urol"},{"issue":"4\u2005s","key":"2026032704271243600_lvaf222-B225","first-page":"S117","article-title":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"105","year":"2024","journal-title":"Kidney Int"},{"issue":"4","key":"2026032704271243600_lvaf222-B226","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/cen.13927","article-title":"Cardiovascular findings in patients with nonsurgical hypoparathyroidism and pseudohypoparathyroidism: A cohort study","volume":"90","author":"Underbjerg","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"2026032704271243600_lvaf222-B227","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1210\/clinem\/dgab162","article-title":"Basal Ganglia Calcification Is Associated With Local and Systemic Metabolic Mechanisms in Adult Hypoparathyroidism","volume":"106","author":"Zavatta","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026032704271243600_lvaf222-B228","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1530\/EJE-18-0580","article-title":"Long-term complications in patients with chronic hypoparathyroidism: a cross-sectional study","volume":"180","author":"David","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2026032704271243600_lvaf222-B229","doi-asserted-by":"crossref","first-page":"e0232842","DOI":"10.1371\/journal.pone.0232842","article-title":"Prevalence and complications of nonsurgical hypoparathyroidism in Korea: A nationwide cohort study","volume":"15","author":"Kim","year":"2020","journal-title":"PLoS One"},{"issue":"5","key":"2026032704271243600_lvaf222-B230","doi-asserted-by":"crossref","first-page":"e2215","DOI":"10.1210\/clinem\/dgab038","article-title":"Impaired Immune Function in Patients With Chronic Postsurgical Hypoparathyroidism: Results of the EMPATHY Study","volume":"106","author":"Puliani","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026032704271243600_lvaf222-B231","first-page":"1617","article-title":"Bone mineral density in patients with chronic hypoparathyroidism","volume":"76","author":"Abugassa","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2026032704271243600_lvaf222-B232","first-page":"2135","article-title":"Attenuation of postmenopausal high turnover bone loss in patients with hypoparathyroidism","volume":"80","author":"Fujiyama","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026032704271243600_lvaf222-B233","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00000441-199508000-00003","article-title":"Hypoparathyroidism counteracts risk factors for osteoporosis","volume":"310","author":"Touliatos","year":"1995","journal-title":"Am J Med Sci"},{"issue":"1","key":"2026032704271243600_lvaf222-B234","first-page":"251","article-title":"Vertebral Fractures and Bone Mineral Density in Patients With Idiopathic Hypoparathyroidism on Long-Term Follow-Up","volume":"102","author":"Chawla","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2026032704271243600_lvaf222-B235","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1007\/s00198-021-05966-8","article-title":"Fracture risk in hypoparathyroidism: a systematic review and meta-analysis","volume":"32","author":"Pal","year":"2021","journal-title":"Osteoporos Int"},{"issue":"5","key":"2026032704271243600_lvaf222-B236","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s11914-023-00790-x","article-title":"Fracture Risk in Patients with Hypoparathyroidism","volume":"21","author":"Rejnmark","year":"2023","journal-title":"Curr Osteoporos Rep"},{"issue":"5","key":"2026032704271243600_lvaf222-B237","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1159\/000320481","article-title":"Overestimation of lumbar spine calcium with dual energy X-ray absorptiometry scanning due to the prescription of lanthanum carbonate in patients with chronic kidney disease","volume":"32","author":"Furstenberg","year":"2010","journal-title":"Am J Nephrol"},{"issue":"4","key":"2026032704271243600_lvaf222-B238","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1136\/jim-2015-000043","article-title":"Bone mineral density and biochemical markers of bone metabolism in predialysis patients with chronic kidney disease","volume":"64","author":"Fidan","year":"2016","journal-title":"J Investig Med"},{"key":"2026032704271243600_lvaf222-B239","doi-asserted-by":"crossref","DOI":"10.1007\/s00198-025-07410-7","article-title":"Skeletal health status among patients with chronic hypoparathyroidism: results from the Canadian National Hypoparathyroidism Registry (CNHR)","author":"Khan","year":"2025","journal-title":"Osteoporos Int"},{"key":"2026032704271243600_lvaf222-B240","doi-asserted-by":"crossref","DOI":"10.1093\/jbmr\/zjaf061","article-title":"Increased risk of vertebral fractures and reduced risk of femur fractures in patients with chronic hypoparathyroidism: a Nationwide cohort study in Sweden","author":"Bjornsdottir","year":"2025","journal-title":"J Bone Miner Res"},{"issue":"10","key":"2026032704271243600_lvaf222-B241","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1002\/jbmr.4659","article-title":"Autosomal Dominant Hypocalcemia Type 1: A Systematic Review","volume":"37","author":"Roszko","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2026032704271243600_lvaf222-B242","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1210\/clinem\/dgae769","article-title":"CASRdb: A Publicly Accessible Comprehensive Database for Disease-Associated Calcium-Sensing Receptor Variants","volume":"110","author":"Charoenngam","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"26","key":"2026032704271243600_lvaf222-B243","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1056\/NEJMoa1300253","article-title":"Mutations affecting G-protein subunit alpha11 in hypercalcemia and hypocalcemia","volume":"368","author":"Nesbit","year":"2013","journal-title":"N Engl J Med"},{"issue":"6","key":"2026032704271243600_lvaf222-B244","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/jbmr.4803","article-title":"GNA11 Variants Identified in Patients with Hypercalcemia or Hypocalcemia","volume":"38","author":"Howles","year":"2023","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2026032704271243600_lvaf222-B245","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1210\/jcem.81.4.8636323","article-title":"Clustered inactivating mutations and benign polymorphisms of the calcium receptor gene in familial benign hypocalciuric hypercalcemia suggest receptor functional domains","volume":"81","author":"Heath","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2026032704271243600_lvaf222-B246","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.1210\/jcem.86.11.8016","article-title":"Activating mutations of the calcium-sensing receptor: management of hypocalcemia","volume":"86","author":"Lienhardt","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"9261","key":"2026032704271243600_lvaf222-B247","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0140-6736(00)04254-9","article-title":"Genetic developments in hypoparathyroidism","volume":"357","author":"Thakker","year":"2001","journal-title":"Lancet"},{"key":"2026032704271243600_lvaf222-B248","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3389\/fphys.2016.00458","article-title":"Autosomal Dominant Hypocalcemia (Hypoparathyroidism) Types 1 and 2","volume":"7","author":"Roszko","year":"2016","journal-title":"Front Physiol"},{"issue":"7","key":"2026032704271243600_lvaf222-B249","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1210\/jcem.87.7.8639","article-title":"Hydrochlorothiazide effectively reduces urinary calcium excretion in two Japanese patients with gain-of-function mutations of the calcium-sensing receptor gene","volume":"87","author":"Sato","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026032704271243600_lvaf222-B250","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/cen.14969","article-title":"Pregnancy, delivery and neonatal outcomes among women with hypoparathyroidism-A population-based study","volume":"99","author":"Hochberg","year":"2023","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2026032704271243600_lvaf222-B251","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ecl.2005.09.004","article-title":"Calcium and bone disorders during pregnancy and lactation","volume":"35","author":"Kovacs","year":"2006","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"5","key":"2026032704271243600_lvaf222-B252","doi-asserted-by":"crossref","first-page":"bvac031","DOI":"10.1210\/jendso\/bvac031","article-title":"Subcutaneous Infusion of rhPTH(1-34) During Pregnancy and Nursing in a Woman With Autosomal Dominant Hypoparathyroidism 1","volume":"6","author":"Shulman","year":"2022","journal-title":"J Endocr Soc"},{"issue":"9","key":"2026032704271243600_lvaf222-B253","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3109\/09513590.2013.813473","article-title":"The effect of continuous subcutaneous recombinant PTH (1-34) infusion during pregnancy on calcium homeostasis - a case report","volume":"29","author":"Ilany","year":"2013","journal-title":"Gynecol Endocrinol"},{"issue":"6","key":"2026032704271243600_lvaf222-B254","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1210\/clinem\/dgac734","article-title":"Approach to the Patient: Management of Parathyroid Diseases Across Pregnancy","volume":"108","author":"Appelman-Dijkstra","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2026032704271243600_lvaf222-B255","article-title":"Use of rhPTH(1-84) for hypoparathyroidism during early pregnancy and lactation","volume":"2023","author":"Liao","year":"2023","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"3","key":"2026032704271243600_lvaf222-B256","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/cen.14212","article-title":"Changes in treatment needs of hypoparathyroidism during pregnancy and lactation: A case series","volume":"93","author":"Hartogsohn","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2026032704271243600_lvaf222-B257","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/s13023-021-02053-3","article-title":"Hypoparathyroidism and pseudohypoparathyroidism in pregnancy: an Italian retrospective observational study","volume":"16","author":"Marcucci","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"12","key":"2026032704271243600_lvaf222-B258","first-page":"e5054","article-title":"Changes in Serum Calcium and Treatment of Hypoparathyroidism During Pregnancy and Lactation: A Single-center Case Series","volume":"106","author":"Wang","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"3 Pt 2","key":"2026032704271243600_lvaf222-B259","first-page":"485","article-title":"Hypercalcemia in a calcitriol-treated hypoparathyroid woman during lactation","volume":"76","author":"Caplan","year":"1990","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2026032704271243600_lvaf222-B260","first-page":"254","article-title":"Hypoparathyroidism and pregnancy","volume":"243","author":"Sadeghi-Nejad","year":"1980","journal-title":"Treatment with calcitriol. JAMA"},{"issue":"4","key":"2026032704271243600_lvaf222-B261","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1210\/jcem-52-4-810","article-title":"Hypoparathyroidism during pregnancy: treatment with calcitriol","volume":"52","author":"Salle","year":"1981","journal-title":"J Clin Endocrinol Metab"},{"key":"2026032704271243600_lvaf222-B262","volume-title":"Endotext","author":"Kovacs","year":"2000"},{"key":"2026032704271243600_lvaf222-B263","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1210\/jcem-24-6-512","article-title":"Effect of Pregnancy and of the Menstrual Cycle on Hypoparathyroidism","volume":"24","author":"Graham","year":"1964","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2026032704271243600_lvaf222-B264","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1152\/physrev.00014.2014","article-title":"Bone development and mineral homeostasis in the fetus and neonate: roles of the calciotropic and phosphotropic hormones","volume":"94","author":"Kovacs","year":"2014","journal-title":"Physiol Rev"},{"issue":"6","key":"2026032704271243600_lvaf222-B265","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.beem.2011.07.001","article-title":"Disorders of calcium metabolism and parathyroid disease","volume":"25","author":"Cooper","year":"2011","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"2026032704271243600_lvaf222-B266","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1210\/jcem.84.2.5486","article-title":"Maintenance of serum calcium by parathyroid hormone-related peptide during lactation in a hypoparathyroid patient","volume":"84","author":"Mather","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026032704271243600_lvaf222-B267","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1365-2265.1987.tb00824.x","article-title":"Remission of hypoparathyroidism during lactation: evidence for a physiological role for prolactin in the regulation of vitamin D metabolism","volume":"26","author":"Cundy","year":"1987","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"2026032704271243600_lvaf222-B268","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1471-0528.1983.tb06774.x","article-title":"Vitamin D metabolism in normal and hypoparathyroid pregnancy and lactation","volume":"90","author":"Markestad","year":"1983","journal-title":"Case report. Br J Obstet Gynaecol"},{"issue":"3","key":"2026032704271243600_lvaf222-B269","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1507\/endocrj1954.31.227","article-title":"Postpartum resolution of hypocalcemia in a lactating hypoparathyroid patient","volume":"31","author":"Rude","year":"1984","journal-title":"Endocrinol Jpn"},{"issue":"4","key":"2026032704271243600_lvaf222-B270","doi-asserted-by":"crossref","first-page":"198","DOI":"10.4158\/EP.5.4.198","article-title":"Hypercalcemia in a woman with hypoparathyroidism associated with increased parathyroid hormone-related protein during lactation","volume":"5","author":"Shomali","year":"1999","journal-title":"Endocr Pract"},{"issue":"5635","key":"2026032704271243600_lvaf222-B271","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/bmj.1.5635.23","article-title":"Post-partum hypercalcaemia in treated hypoparathyroidism","volume":"1","author":"Wright","year":"1969","journal-title":"Br Med J"},{"issue":"2","key":"2026032704271243600_lvaf222-B272","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1210\/jc.2015-2175","article-title":"Global Consensus Recommendations on Prevention and Management of Nutritional Rickets","volume":"101","author":"Munns","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2026032704271243600_lvaf222-B273","doi-asserted-by":"crossref","first-page":"eRC1142","DOI":"10.31744\/einstein_journal\/2025RC1142","article-title":"Kabuki and CHARGE syndromes: overlapping symptoms and diagnostic challenges","volume":"23","author":"Cerqueira","year":"2025","journal-title":"Einstein (Sao Paulo)"},{"issue":"9","key":"2026032704271243600_lvaf222-B274","doi-asserted-by":"crossref","first-page":"e754","DOI":"10.1210\/clinem\/dgad147","article-title":"Expanding the Phenotypic Spectrum of Kenny-Caffey Syndrome","volume":"108","author":"Schigt","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2026032704271243600_lvaf222-B275","doi-asserted-by":"crossref","first-page":"671","DOI":"10.4158\/EP13328.OR","article-title":"Understanding the burden of illness associated with hypoparathyroidism reported among patients in the PARADOX study","volume":"20","author":"Hadker","year":"2014","journal-title":"Endocr Pract"},{"issue":"7","key":"2026032704271243600_lvaf222-B276","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/s40618-020-01442-y","article-title":"Burden of illness in patients with chronic hypoparathyroidism not adequately controlled with conventional therapy: a Belgium and the Netherlands survey","volume":"44","author":"Hamdy","year":"2021","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"2026032704271243600_lvaf222-B277","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1007\/s12325-021-01649-2","article-title":"Risk of Nephrolithiasis and Nephrocalcinosis in Patients with Chronic Hypoparathyroidism: A Retrospective Cohort Study","volume":"38","author":"Ketteler","year":"2021","journal-title":"Adv Ther"},{"issue":"6","key":"2026032704271243600_lvaf222-B278","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1210\/jc.2013-1239","article-title":"The effect of PTH(1-84) on quality of life in hypoparathyroidism","volume":"98","author":"Cusano","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026032704271243600_lvaf222-B279","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1210\/jc.2012-2984","article-title":"Therapy of hypoparathyroidism with PTH(1-84): a prospective four-year investigation of efficacy and safety","volume":"98","author":"Cusano","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2026032704271243600_lvaf222-B280","doi-asserted-by":"crossref","first-page":"16033","DOI":"10.1038\/nrdp.2016.33","article-title":"Primary hyperparathyroidism","volume":"2","author":"Bilezikian","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"2026032704271243600_lvaf222-B281","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.semnephrol.2011.09.008","article-title":"Diuretics and disorders of calcium homeostasis","volume":"31","author":"Grieff","year":"2011","journal-title":"Semin Nephrol"},{"issue":"6","key":"2026032704271243600_lvaf222-B282","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1172\/JCI24134","article-title":"Enhanced passive Ca2+ reabsorption and reduced Mg2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia","volume":"115","author":"Nijenhuis","year":"2005","journal-title":"J Clin Invest"},{"issue":"3","key":"2026032704271243600_lvaf222-B283","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1210\/jc.2015-3964","article-title":"Thiazide-Associated Hypercalcemia: Incidence and Association With Primary Hyperparathyroidism Over Two Decades","volume":"101","author":"Griebeler","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"2026032704271243600_lvaf222-B284","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4158\/EP10281.RA","article-title":"Medications that affect calcium","volume":"17","author":"Ruppe","year":"2011","journal-title":"Endocr Pract"},{"issue":"1","key":"2026032704271243600_lvaf222-B285","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s43441-024-00712-8","article-title":"Hypocalcemia Event Associated with Denosumab: A Real-World Study from FDA Adverse Event Reporting System (FAERS) Database","volume":"59","author":"Gao","year":"2025","journal-title":"Ther Innov Regul Sci"},{"issue":"6","key":"2026032704271243600_lvaf222-B286","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00774-009-0119-x","article-title":"A review of drug-induced hypocalcemia","volume":"27","author":"Liamis","year":"2009","journal-title":"J Bone Miner Metab"},{"issue":"5","key":"2026032704271243600_lvaf222-B287","doi-asserted-by":"crossref","first-page":"322","DOI":"10.7150\/ijms.4397","article-title":"Omeprazole- and esomeprazole-associated hypomagnesaemia: data mining of the public version of the FDA Adverse Event Reporting System","volume":"9","author":"Tamura","year":"2012","journal-title":"Int J Med Sci"},{"issue":"2","key":"2026032704271243600_lvaf222-B288","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1056\/NEJM198507113130202","article-title":"Calcium absorption and achlorhydria","volume":"313","author":"Recker","year":"1985","journal-title":"N Engl J Med"},{"key":"2026032704271243600_lvaf222-B289","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3389\/fonc.2020.00779","article-title":"Electrolyte Disorders Induced by Antineoplastic Drugs","volume":"10","author":"Verzicco","year":"2020","journal-title":"Front Oncol"},{"issue":"3","key":"2026032704271243600_lvaf222-B290","first-page":"e56755","article-title":"A Comprehensive Review on Unveiling the Journey of Digoxin: Past, Present, and Future Perspectives","volume":"16","author":"Khandelwal","year":"2024","journal-title":"Cureus"},{"issue":"8","key":"2026032704271243600_lvaf222-B291","doi-asserted-by":"crossref","first-page":"947","DOI":"10.5858\/2002-126-0947-PEOMOI","article-title":"pH effects on measurements of ionized calcium and ionized magnesium in blood","volume":"126","author":"Wang","year":"2002","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"2026032704271243600_lvaf222-B292","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/MNH.0000000000000327","article-title":"Hungry bone syndrome","volume":"26","author":"Jain","year":"2017","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"7698","key":"2026032704271243600_lvaf222-B293","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0140-6736(71)91122-6","article-title":"Mechanism of hypocalcaemia after thyroidectomy for thyrotoxicosis","volume":"1","author":"Michie","year":"1971","journal-title":"Lancet"},{"issue":"12","key":"2026032704271243600_lvaf222-B294","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1089\/jpm.2013.0389","article-title":"Hungry bone syndrome: persistent hypocalcemia related to osteoblastic bone metastases of prostate cancer","volume":"16","author":"Riveros","year":"2013","journal-title":"J Palliat Med"},{"issue":"1","key":"2026032704271243600_lvaf222-B295","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11154-024-09926-5","article-title":"No longer to be ignored: Hypophosphatemia following intravenous iron administration","volume":"26","author":"Strubbe","year":"2025","journal-title":"Rev Endocr Metab Disord"},{"issue":"7","key":"2026032704271243600_lvaf222-B296","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1210\/jc.2008-2396","article-title":"FGF23 elevation and hypophosphatemia after intravenous iron polymaltose: a prospective study","volume":"94","author":"Schouten","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026032704271243600_lvaf222-B297","first-page":"49","article-title":"Severe hypophosphataemia after intravenous iron administration","volume":"72","author":"Blazevic","year":"2014","journal-title":"Neth J Med"},{"issue":"7","key":"2026032704271243600_lvaf222-B298","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/TP.0b013e3181f00a18","article-title":"Severe hypophosphatemia after intravenous administration of iron carboxymaltose in a stable renal transplant recipient","volume":"90","author":"Mani","year":"2010","journal-title":"Transplantation"},{"issue":"2","key":"2026032704271243600_lvaf222-B299","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/jbmr.4429","article-title":"PTH and FGF23 Exert Interdependent Effects on Renal Phosphate Handling: Evidence From Patients With Hypoparathyroidism and Hyperphosphatemic Familial Tumoral Calcinosis Treated With Synthetic Human PTH 1-34","volume":"37","author":"Ovejero","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2026032704271243600_lvaf222-B300","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s10067-014-2627-x","article-title":"Hypophosphatemic osteomalacia induced by tenofovir in HIV-infected patients","volume":"35","author":"Mateo","year":"2016","journal-title":"Clin Rheumatol"},{"issue":"11","key":"2026032704271243600_lvaf222-B301","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/ki.2010.318","article-title":"Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities","volume":"78","author":"Herlitz","year":"2010","journal-title":"Kidney Int"},{"issue":"1","key":"2026032704271243600_lvaf222-B302","doi-asserted-by":"crossref","first-page":"K21","DOI":"10.1530\/EO-22-0047","article-title":"Hypoparathyroidism: an uncommon adverse effect of treatment with durvalumab","volume":"2","author":"Kreze","year":"2022","journal-title":"Endocr Oncol"},{"issue":"2","key":"2026032704271243600_lvaf222-B303","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1210\/jc.2018-01151","article-title":"Immune Checkpoint Inhibitor-Induced Hypoparathyroidism Associated With Calcium-Sensing Receptor-Activating Autoantibodies","volume":"104","author":"Piranavan","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026032704271243600_lvaf222-B304","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s40425-019-0528-x","article-title":"Inflammation-induced hypoparathyroidism triggered by combination immune checkpoint blockade for melanoma","volume":"7","author":"Trinh","year":"2019","journal-title":"J Immunother Cancer"},{"issue":"7","key":"2026032704271243600_lvaf222-B305","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1200\/JOP.18.00076","article-title":"Autoimmune-Related Primary Hypoparathyroidism Possibly Induced by the Administration of Pembrolizumab: A Case Report","volume":"14","author":"Umeguchi","year":"2018","journal-title":"J Oncol Pract"},{"issue":"7","key":"2026032704271243600_lvaf222-B306","doi-asserted-by":"crossref","first-page":"1039 e5","DOI":"10.1016\/j.ajem.2017.02.048","article-title":"Acute symptomatic hypocalcemia from immune checkpoint therapy-induced hypoparathyroidism","volume":"35","author":"Win","year":"2017","journal-title":"Am J Emerg Med"},{"issue":"1","key":"2026032704271243600_lvaf222-B307","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1172\/JCI21867","article-title":"Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia","volume":"115","author":"Pascussi","year":"2005","journal-title":"J Clin Invest"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/193\/5\/G83\/65274063\/lvaf222.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/193\/5\/G83\/65274063\/lvaf222.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T08:27:49Z","timestamp":1774600069000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/193\/5\/G83\/8321487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":307,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvaf222","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,10,30]]}}}